Research Article

Clinicopathological Profile of Thyroid Carcinomas: A 10-Year Experience in a Tertiary Care Institute

Volume: 6 Number: 1 April 30, 2020
Bahri Ozer *, Oğuz Catal , Songül Peltek Ozer , Mustafa Sit , Hayri Erkol
EN

Clinicopathological Profile of Thyroid Carcinomas: A 10-Year Experience in a Tertiary Care Institute

Abstract

Objective: Thyroid gland is an important endocrine gland and thyroid cancers (TC) are the most noteworthy disease of the thyroid gland. Although thyroid surgery is performed for most particularly for malignancy, thyroidectomies still maintain a large part of surgical operations. We aimed to investigate the incidence and subtypes of the thyroid cancers in present study, with our 10 years experience of thyroid surgery.
Methods: Data of patients who underwent thyroidectomy were retrospectively analyzed. The patients who underwent bilateral total thyroidectomy were included to the study. Patients’ age, gender and histopathological results were recorded. According to the histopathological reports we divided the patients into two groups either as benign or malignant.
Results: A total of 3632 patients were included in the study. 2999 (82.6%) patients were in benign group and 633(17.4%) patients were in malignant group. The subtypes of malignant tumors were papillary carcinoma in 591 (93.4%), medullary carcinoma in 16 (2.5%), follicular carcinoma in 14 (2.2%), oncocytic (hurtle cell) carcinoma in 7 (1.1%) and undifferentiated (anaplastic) in 5(0.8%) of the cases.
Conclusion: Incidental thyroid cancers are not a rare entity after pathological examination of thyroid specimen after surgery. Therefore, we suggest careful evaluation and bilateral leb lobectomy ectomy in surgical treatment of thyroid conditions

Keywords

Thyroid,Benign,Malignant,Multicentricity

References

  1. Akgun Y, Ongoren A, Kuru S, Acar E, Cengiz A, & Gulhan D. Tetany after thyroid surgery. Turkish Medical Journal, 2007;1, 80-85.
  2. Are C, & Shaha A.R. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Annals of surgical oncology, 2006;13(4), 453-464.
  3. Benek S, Kocakusak A, Ozer B, Kizilkaya M.C, Erozgen, F, Ciftci F, Tatar C. The Ever-Changing Configuration of the Completion Thyroidectomy in the Last Decade. Haseki Tip Bulteni, 2015;53(3).
  4. Davies L, & Welch H.G. Current thyroid cancer trends in the United States. JAMA Otolaryngology–Head & Neck Surgery, 2014;140(4), 317-322.
  5. Efremidou E.I, Papageorgiou M.S, Liratzopoulos N, & Manolas K.J. The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Canadian Journal of Surgery, 2009;52(1), 39.
  6. Erbil Y, Barbaros U, Salmaslıoglu A, Yanık B.T, Bozbora A., & Ozarmagan, S. The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter. Langenbeck's archives of surgery, 2006;391(6), 567-573.
  7. Grigsby P.W, Gal‐or A, Michalski J.M, & Doherty G.M. Childhood and adolescent thyroid carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society, 2002;95(4), 724-729.
  8. Hu D, Zhou J, He W, Peng J, Cao Y, Ren H, Xiao Q. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World journal of surgical oncology, 2018;16(1), 30.
  9. Jemal A., Siegel R, Xu J, & Ward E. Cancer statistics, 2010. CA: a cancer journal for clinicians, 2010;60(5), 277-300.
  10. Lee J.-H, & Shin S.W. Overdiagnosis and screening for thyroid cancer in Korea. The Lancet, 2014;384(9957), 1848.
Vancouver
1.Bahri Ozer, Oğuz Catal, Songül Peltek Ozer, Mustafa Sit, Hayri Erkol. Clinicopathological Profile of Thyroid Carcinomas: A 10-Year Experience in a Tertiary Care Institute. Mid Blac Sea J Health Sci. 2020 Apr. 1;6(1):24-7. doi:10.19127/mbsjohs.646535